You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

untreated Follicular lymphoma

Showing 1 - 25 of 8,425
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Follicular Lymphoma Trial in New York (Mosunetuzumab, Tazemetostat Pill)

Not yet recruiting
  • Follicular Lymphoma
  • New York, New York
    Weill Cornell Medicine/NewYork-Presbyterian Hospital
Aug 8, 2023

Follicular Lymphoma, Non-Hodgkin's Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Rituximab, Copanlisib)

Recruiting
  • Follicular Lymphoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Obinutuzumab-based Therapy for Previously Untreated FL

Recruiting
  • Follicular Lymphoma
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
Jun 3, 2023

Lymphoma, Follicular, Follicular Lymphoma Trial in Saint Louis (Mosunetuzumab, Polatuzumab vedotin)

Recruiting
  • Lymphoma, Follicular
  • Follicular Lymphoma
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 14, 2022

Follicular Lymphoma (FL) Trial in Noblesville (Odronextamab, Rituximab, Cyclophosphamide)

Recruiting
  • Follicular Lymphoma (FL)
  • Noblesville, Indiana
    Investigative Clinical Research of Indiana
Oct 18, 2023

Follicular Lymphoma Trial in Duarte, Irvine (procedure, other, biological, drug)

Not yet recruiting
  • Follicular Lymphoma
  • Biospecimen Collection
  • +7 more
  • Duarte, California
  • +1 more
Oct 27, 2023

Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage III Follicular Lymphoma, Ann Arbor Stage IV Follicular Lymphoma Trial in

Recruiting
  • Ann Arbor Stage II Follicular Lymphoma
  • +5 more
  • Fresno, California
  • +2 more
Jan 24, 2023

Follicular Lymphoma, Tumor Trial in Houston (Obinutuzumab, CC-99282)

Not yet recruiting
  • Follicular Lymphoma
  • Tumor
  • Houston, Texas
    M D Anderson Cancer Center
Oct 30, 2023

Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Ann

Active, not recruiting
  • Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma
  • +11 more
  • Washington, District of Columbia
  • +6 more
Feb 2, 2023

Peripheral T Cell Lymphoma, Epigenetic Repression Trial in Tianjin (Chidamide, Azacitidine)

Recruiting
  • Peripheral T Cell Lymphoma
  • Epigenetic Repression
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jul 14, 2023

Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype Trial in Guangzhou (Chidamide combined with CHOP,

Recruiting
  • Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype
  • Guangzhou, Guangdong, China
    Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University
Oct 7, 2022

Follicular Lymphoma (FL) Trial in Westbury (Odronextamab, Rituximab, Cyclophosphamide)

Recruiting
  • Follicular Lymphoma (FL)
  • Westbury, New York
    Clinical Research Alliance Inc
Oct 13, 2023

Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2 Follicular Lymphoma, Ann Arbor Stage II Grade 1

Active, not recruiting
  • Ann Arbor Stage I Grade 1 Follicular Lymphoma
  • +9 more
  • Quality-of-Life Assessment
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Feb 3, 2022

Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma Trial in Atlanta (drug, biological,

Recruiting
  • Grade 1 Follicular Lymphoma
  • +7 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Dec 7, 2021

Ann Arbor Stage II Grade 1 Follicular Lymphoma, Ann Arbor Stage II Grade 2 Follicular Lymphoma, Ann Arbor Stage III Grade 1

Active, not recruiting
  • Ann Arbor Stage II Grade 1 Follicular Lymphoma
  • +12 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 18, 2022

Lymphoma Trial in Norway, Sweden, Switzerland (Rituximab, lenalidomide)

Active, not recruiting
  • Lymphoma
  • Bergen, Norway
  • +32 more
Sep 27, 2022

Follicular Lymphoma Trial in Boston (Lethally Irradiated Lymphoma cells with GM-CSF K562 Cells)

Active, not recruiting
  • Follicular Lymphoma
  • Lethally Irradiated Lymphoma cells with GM-CSF K562 Cells
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Feb 28, 2022

Indolent Non-Hodgkin Lymphoma Trial in München (Ibrutinib, GA 101)

Active, not recruiting
  • Indolent Non-Hodgkin Lymphoma
  • München, Bavaria, Germany
    Klinikum der Universität München
May 6, 2021

Peripheral T-cell Lymphoma Targeted Therapy Trial in Tianjin (Azacitidine, Chidamide, Cyclophosphamide)

Enrolling by invitation
  • Peripheral T-cell Lymphoma Targeted Therapy
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Insititute & Hospital
Jan 9, 2023

Lymphoma, Follicular Trial in United States (Bendamustine, Rituximab, Y-90 ibritumomab)

Completed
Has Results
  • Lymphoma, Follicular
  • Scarborough, Maine
  • +3 more
Apr 27, 2021

Follicular Lymphoma Trial in United States (Zevalin, Rituximab)

Terminated
Has Results
  • Follicular Lymphoma
  • Sun City, Arizona
  • +4 more
Sep 6, 2021

Follicular Lymphoma Trial in Germany (Copanlisib, Obinutuzumab)

Recruiting
  • Follicular Lymphoma
  • München, Bavaria, Germany
  • +39 more
May 19, 2022

Follicular Lymphoma, Indolent B-Cell Non-Hodgkin Lymphoma, Marginal Zone Lymphoma Trial in Seattle (Laboratory Biomarker

Active, not recruiting
Has Results
  • Follicular Lymphoma
  • +2 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 6, 2022

Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage II Marginal Zone Lymphoma, Ann Arbor Stage III Follicular Lymphoma Trial

Active, not recruiting
  • Ann Arbor Stage II Follicular Lymphoma
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 3, 2022

Follicular Lymphoma Trial in United States (DRL_RI (Proposed rituximab biosimilar), MabThera®)

Active, not recruiting
  • Follicular Lymphoma
  • DRL_RI (Proposed rituximab biosimilar)
  • MabThera®
  • Whittier, California
  • +3 more
May 27, 2022